Julie Grant is a General Partner at Canaan, a $5B technology and healthcare venture capital firm, where she leads biopharma investments and company formation on the West Coast. She co-founded and served as founding CEO of Day One Biopharmaceuticals, a purpose-built pediatric oncology company that grew to a $1.5B+ valuation and was later acquired by Servier. A Yale-educated molecular biophysicist who went on to Stanford MBA and Cambridge MPhil, Grant brings rare operational depth to venture - having sat in the CEO chair before returning to investing. In 2023, President Biden appointed her to the National Cancer Advisory Board. She is the fourth woman to become a General Partner at Canaan.
Richard 'Rich' Boyle is a General Partner at Canaan, a leading venture capital firm, where he focuses on real estate technology, artificial intelligence, robotics, and marketplaces. With over 25 years building companies in Silicon Valley - including serving as President, Chairman, and CEO of LoopNet, which he took public in 2006 before a $900M acquisition by CoStar Group in 2012 - Boyle brings rare operator depth to his investing. He joined Canaan in 2016 after a stint as Operating Partner at Khosla Ventures, and has since backed companies including ApartmentList, Berkshire Grey, Diligent Robotics, Dusty Robotics, Hermeus, and Tomorrow.io.